Results 81 to 90 of about 2,740,951 (332)

Development of Swiss Biotechnology Beyond the Biopharmaceutical Sector In memoriam Prof. Dr. Oreste Ghisalba (1946–2018)

open access: yesCHIMIA, 2020
Although diverse, the potential business opportunities for biotechnology outside the biopharmaceutical market are very large. White biotechnology can offer sustainable operations and products, while investments tend to be lower than those in red ...
Hans-Peter Meyer, Oleg Werbitzky
doaj   +1 more source

Societal and Ethical Issues in Industrial Biotechnology.

open access: yesAdvances in Biochemical Engineering/Biotechnology, 2019
In this chapter we aim to give an overview of the main societal and ethical issues that are currently voiced around industrial biotechnology. We will illustrate this with some recent cases, such as the development of synthetic artemisinin, synthetic ...
L. Asveld, P. Osseweijer, John Posada
semanticscholar   +1 more source

The current biotechnology outlook in Malaysia [PDF]

open access: yes
Blessed with extremely rich biodiversity, Malaysia is all geared up to explore new high technology to utilize the advantage it possesses whilst to protect its environment.
Khairiah Salwa MOKHTAR, Ravi MAHALINGAM
core  

Co‐Electrospinning Extracellular Matrix with Polycaprolactone Enables a Modular Approach to Balance Bioactivity and Mechanics of a Multifunctional Bone Wrap

open access: yesAdvanced Healthcare Materials, EarlyView.
The incorporation of nondigested ECM and synthetic polymers into a co‐electrospinning system enables the decoupling of bioactivity and mechanical properties within a single wrap. This technique is used to develop a multifunctional bone wrap that achieves augmented membrane durability, sustained infection control, and enhanced vascularity for use in ...
Sarah Jones   +14 more
wiley   +1 more source

THE IMPACT OF REGULATION ON THE DEVELOPMENT OF NEW PRODUCTS IN THE FOOD INDUSTRY [PDF]

open access: yes
Paper prepared for presentation at the 8th ICABR International Conference on Agricultural Biotechnology: International Trade and Domestic Production Ravello (Italy), July 8 to 11th, 2004Food industry, Regulation, Innovation, Biotechnology, Organic food ...
Blind, Knut, Menrad, Klaus
core   +1 more source

Lysosome‐Acidifying Nanoparticles Rescue A30P α‐Synuclein Induced Neuronal Death in Cellular and Drosophila Models of Parkinson's Disease

open access: yesAdvanced Healthcare Materials, EarlyView.
Lysosome‐targeted acidic nanoparticles based on a biodegradable poly(ethylene tetrafluorosuccinate‐co‐succinate) copolymer are engineered to restore impaired lysosomal acidification through pH‐responsive intracellular degradation. Localized acid release enhances autophagic proteolysis, reduces α‐synuclein accumulation, and preserves dopaminergic neuron
Chih Hung Lo   +6 more
wiley   +1 more source

THE REGULATORY REGIME AND ITS IMPACT ON INNOVATION ACTIVITIES IN AGRO-FOOD BIOTECHNOLOGY IN THE EU AND USA [PDF]

open access: yes
Paper prepared for presentation at the Conference: “Seeds of Change: Intellectual Property Protection for Agricultural Biotechnology” University of Illinois at Urbana-Champaign (USA), April 8 to 10th, 2004Agro-food Biotechnology, Innovation, European ...
Menrad, Klaus
core   +1 more source

Computational Modeling Meets 3D Bioprinting: Emerging Synergies in Cardiovascular Disease Modeling

open access: yesAdvanced Healthcare Materials, EarlyView.
Emerging advances in three‐dimensional bioprinting and computational modeling are reshaping cardiovascular (CV) research by enabling more realistic, patient‐specific tissue platforms. This review surveys cutting‐edge approaches that merge biomimetic CV constructs with computational simulations to overcome the limitations of traditional models, improve ...
Tanmay Mukherjee   +7 more
wiley   +1 more source

Marine microalgae and their industrial biotechnological applications: A review

open access: yesJournal of Genetic Engineering and Biotechnology
Background: For use in specialized programs in the food, pharmaceutical, nutraceutical, cosmetic, and animal feed sectors, micro-algal biomass has been generated industrially.
Reham Gamal, Mohamed Attia Shreadah
doaj   +1 more source

THE SOURCE OF COMPARATIVE ADVANTAGE IN THE BIOTECHNOLOGY INDUSTRY: A REAL OPTIONS APPROACH [PDF]

open access: yes
Sources of heterogeneity within the process of R&D investment, such as international differences in the maximum per-period rate of investment and level of regulatory uncertainty, offer a plausible explanation for US comparative advantage in biotechnology.
Lavoie, Brian F., Sheldon, Ian M.
core   +1 more source

Home - About - Disclaimer - Privacy